Basic information
Biomarker: Snail
Histology type: endometrial carcinoma
Cohort characteristics
Country: Japanese
Region: Osaka
Followed up time :
Subgroup 1 name : negative
Subgroup 1 number: 292
Subgroup 2 name: positive
Subgroup 2 number: 60
Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
---|---|---|---|---|---|---|---|---|
384 | primary EC | 354 | metastases of endometrial carcinomas | 30 |
Sample information
Conclusion: The current study is the first report to demonstrate that the EMT status, as represented by both reduced E-cadherin expression and nuclear Snail expression, was identified to be an independent predictive factor of patient survival in endometrial cancer.
Sample type : tissue
Sample method: immunohistochemistry
Expression pattern : EMT (reduced E-cadherin and nuclear expression of Snail )
Expression elevation: E-cadherin expression was scored as: 0 (no stain), 1+ (low intensity immunoreactivity in more than 10% of tumor cells), 2+ (medium intensity immunoreactivity of more than 10% of tumor cells), 3+ (high intensity immunoreactivity of more than 10% of tumor cells). These data were summarized into two groups; preserved E-cadherin (3+) and reduced E-cadherin (0, 1+, 2+). The Snail and Slug expressions were evaluated as positive only when nuclear staining was detectable: 0 (no stain), 1+ (immunoreactivity of more than 1% of tumor cells), 2+ (immunoreactivity of more than 2–5% of tumor cells), 3+ (immunoreactivity of more than 5% of tumor cells), then divided into two groups, negative (0), and positive (1+, 2+, 3+). Scoring was performed three times per slide for three distinct fields, and the three scores were averaged.
Disease information
Statictics: cutoff<50;cutoff>50
Cohort age: 68;286
Subgroup 1 age: 64;230
Subgroup 2 age: 4;56
Related information
Funtion Uniprot: Involved in induction of the epithelial to mesenchymal transition (EMT), formation and maintenance of embryonic mesoderm, growth arrest, survival and cell migration. Binds to 3 E-boxes of the E-cadherin/CDH1 gene promoter and to the promoters of CLDN7 and KRT8 and, in association with histone demethylase KDM1A which it recruits to the promoters, causes a decrease in dimethylated H3K4 levels and represses transcription (PubMed:20389281, PubMed:20562920). The N-terminal SNAG domain competes with histone H3 for the same binding site on the histone demethylase complex formed by KDM1A and RCOR1, and thereby inhibits demethylation of histone H3 at 'Lys-4' (in vitro) (PubMed:20389281, PubMed:21300290, PubMed:23721412). During EMT, involved with LOXL2 in negatively regulating pericentromeric heterochromatin transcription (By similarity). SNAI1 recruits LOXL2 to pericentromeric regions to oxidize histone H3 and repress transcription which leads to release of heterochromatin component CBX5/HP1A, enabling chromatin reorganization and acquisition of mesenchymal traits (By similarity). Associates with EGR1 and SP1 to mediate tetradecanoyl phorbol acetate (TPA)-induced up-regulation of CDKN2B, possibly by binding to the CDKN2B promoter region 5'-TCACA-3. In addition, may also activate the CDKN2B promoter by itself
UniProt ID: O95863
UniProt Link: https://www.uniprot.org/uniprotkb/O95863/entry
Molecular function from UniProt:
Tissue specificity from UniProt: Expressed in a variety of tissues with the highest expression in kidney. Expressed in mesenchymal and epithelial cell lines.
Subcellular UniProt: #Cytoplasm #Nucleus
Alternative name from UniProt:
Caution: The interaction with mouse KPNA2 may prevent SNAI1 nuclear import.
Recommended name: Zinc finger protein SNAI1
Gene name from HGNC: SNAI1 (SLUGH2, SNA, SNAH, SNAIL, SNAIL1)
HPA class: Transcription factors
AlphaFold DB: O95863
AlphaFold Link: https://alphafold.ebi.ac.uk/entry/O95863
Induction: Induced by TPA maximally by 2.5-fold at 4 hours, in HepG2 cells (at protein level).
HPA link: https://www.proteinatlas.org/ENSG00000124216-SNAI1
Tissue specificity RNA from HPA: Tissue enhanced (adipose tissue)
Tissue expression from HPA: Ubiquitous nuclear expression.
Single cell type specificity Cell type enhanced (Adipocytes, Extravillous trophoblasts, Endothelial cells)
Immune cell specificity: Immune cell enhanced (plasmacytoid DC)
Subcellular summary HPA Located in Nucleoplasm
Cancer prognostic summary HPA Prognostic marker in renal cancer (unfavorable), thyroid cancer (unfavorable), lung cancer (unfavorable) and colorectal cancer (unfavorable)
Pathology link: https://www.proteinatlas.org/ENSG00000124216-SNAI1/pathology
Pathology endo: https://www.proteinatlas.org/ENSG00000124216-SNAI1/pathology/endometrial+cancer
Expression figure legend: Survival curves generated by using the Kaplan-Meier method in 354 endometrial cancer patients.
Expression figure link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566047/figure/F2/?report=objectonly
OMIM: 604238
OMIM link2: https://www.omim.org/entry/604238
HGNC ID: HGNC:11128
HGNC link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:11128